Next-generation Cologuard Test Demonstrates 94 Percent Sensitivity for Colorectal Cancer …

PRNewswire/ — Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced positive top-line …

Share on Facebook

Tweet

Follow us

Save